The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 2012, is shown as follows: 1 Dec 31, 2013 Dec 31, 2012 2 Assets 3 Cash $626,640.00 $585,760.00 226,900.00 208,390.00 641,350.00 616,130.00 0.00 *239,300.00 328,730.00 0.00 705,940,00 553,530.00 (166,970.00) (148,000.00) $2,362,590.00 $2,055, 110.00 10 Accounts receivable (net) 5 Inventories 6 Investments 7 Land * Equipment 9 Accumulated depreciation-equipment Total assets Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating expenses) 14 Dividends payable 15 Common stock, 54 par 16 Paid-in capital: Excess of issue price over par-common stock 17. Retained earings Total liabilities and stockholders' equity 11 $425,140.00 $404,540.00 42,020.00 52,750.00 23,580.00 19,500.00 154,000.00 100,000.00 416,600.00 279,400.00 1,301,250.00 1.198,920.00 $2,362,590.00 $2,055,110.00 18 Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: A. The investments were sold for $279,880 cash. B. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. D. The common stock was issued for cash. E. There was a $198,010 credit to Retained Earnings for net income. F. There was a $95,680 debit to Retained Earnings for cash dividends declared. bers and AM Um Descriptor Cash paid for dividends Cash paid for merchandise Cash paid for purchase of equipment Cash paid for purchase of land Cash received from customers Cash received from sale of common stock Cash received from sale of investments Change in cash December 31, 20Y3 Decrease in accounts payable Decrease in accounts receivable Decrease in accrued expenses payable Decrease in inventories Depreciation For the Year Ended December 31, 20Y3 Gain on sale of investments Increase in accounts payable Increase in accounts receivable Increase in accrued expenses payable Increase in inventories Loss on sale of investments Net cash flow from operating activities Net cash flow used for operating activities Net cash flow from investing activities Loss on sale of investments Net cash flow from operating activities Net cash flow used for operating activities Net cash flow from investing activities Net cash flow used for investing activities Net cash flow from financing activities Net cash flow used for financing activities Net income Net loss Livers Inc. Statement of Cash Flows (Label) 1 Cash flows from operating activities: 2 Adjustments to reconcile net income to net cash flow from operating activities: 4 5 6 Changes in current operating assets and liabilities: 7 9 30 11 12 13 Cash flows from investing activities: 14 15 16 17 18 19 Cash flows from financing activities: 19 Cash flows from financing activities: 20 21 22 25 24 Cash at the beginning of the year 25 Cash at the end of the year
